Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Monthly Archives: February 2013

New Study Finds Clinical Screenings Poor Predictors of Oral Cancer

ASDAAccording to the National Cancer Institute, an estimated 40,250 people were diagnosed with cancer of the oral cavity and pharynx in the United States in 2012. The five-year survival rate for those diagnosed with early-stage oral and pharyngeal cancers is 82.4 percent. The five-year survival rate of those diagnosed with late-stage metastasized oral and pharyngeal cancers is 34.9 percent. [Read more…]